BRIEF published on 05/06/2024 at 19:25, 1 year 9 months ago Araceli Biosciences Welcomes New CEO Matt Beaudet Innovation Biotechnology CEO Appointment Leadership Matt Beaudet
BRIEF published on 05/06/2024 at 19:25, 1 year 9 months ago Araceli Biosciences accueille le nouveau PDG Matt Beaudet Innovation Biotechnologie Direction Nomination Du PDG Matthieu Beaudet
PRESS RELEASE published on 05/06/2024 at 19:20, 1 year 9 months ago Araceli Biosciences Introduces Matt Beaudet as New President and Chief Executive Officer Araceli Biosciences appoints Matthew Beaudet as CEO, bringing over two decades of biotech industry experience. Board confident in his leadership for company growth and innovation CEO Appointment Biotech Industry Company Growth Matt Beaudet Araceli Biosciences
Published on 02/20/2026 at 15:45, 1 hour 27 minutes ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 2 hours 42 minutes ago Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 14:08, 3 hours 4 minutes ago Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange
Published on 02/20/2026 at 14:00, 3 hours 12 minutes ago Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors
Published on 02/20/2026 at 13:30, 3 hours 42 minutes ago ESGold Launches 70 km2 District-Scale ANT Survey at Montauban Following 3D Model Identifying Deep, Expanding 2 km Mineralized Corridor
Published on 02/20/2026 at 17:05, 7 minutes ago Eurobattery Minerals publishes its year-end report for 2025 while working on design & construction of the tungsten processing plant at San Juan
Published on 02/20/2026 at 15:24, 1 hour 47 minutes ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 02/20/2026 at 15:23, 1 hour 48 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 02/20/2026 at 09:28, 7 hours 44 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026
Published on 02/20/2026 at 09:28, 7 hours 44 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026
Published on 02/20/2026 at 07:30, 9 hours 42 minutes ago Aankondiging inkoop eigen aandelen in het kader van een aandelenaankoopplan
Published on 02/20/2026 at 07:30, 9 hours 42 minutes ago Announcement of share buyback in the context of a share purchase plan
Published on 02/20/2026 at 07:30, 9 hours 42 minutes ago Announcement of share buyback in the context of a share purchase plan
